Sign in
CEMI Stock Price, Chart, Stats & News
Chembio Diagnostics, Inc.
Save
16.71M
Market cap
–
Current P/E
–
Forward P/E
CEMI chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 20.19% |
Operating margin | -42.21% |
Pretax margin | -48.11% |
Net margin | -48.18% |
Effective tax rate | -0.15% |
ROA | -37.20% |
ROE | -89.47% |
D/E | 1.41x |
Interest coverage ratio | -53.41x |
CEMI valuation
P/E | – |
P/S | 0.35x |
P/B | 0.62x |
P/CF | -0.87x |
P/FCF | -1.18x |
P/OCF | -0.87x |
PEG | -0.00x |
EV multiple | -0.67x |
About
Chembio Diagnostics, Inc., along with its subsidiaries, specializes in creating, producing, and bringing to market point-of-care (POC) diagnostic tests used for identifying and diagnosing various diseases. Their current product offerings include tests for critical conditions like COVID-19, HIV/Syphilis, and the Zika virus. Beyond these, the company is dedicated to advancing diagnostics for a wide array of other infectious diseases, such as malaria, dengue, chikungunya, Chagas disease, Ebola, leishmaniasis, Lassa fever, Marburg virus, leptospirosis, rickettsia, and Burkholderia infections.
Similar securities
Based on sector and market capitalization
Report issue